SamuelLentzMD
Obstetrics & Gynecology • Winston Salem, NCGynecologic Oncology, Urogynecology & Pelvic Reconstructive Surgery
Professor of Obstetrics & Gynecology, Wake Forest University
Dr. Lentz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Medical Center Blvd
Winston Salem, NC 27157Phone+1 336-716-6673Fax+1 336-716-4334- Is this information wrong?
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Residency, Obstetrics and Gynecology, 1986 - 1989
Wake Forest University Baptist Medical CenterInternship, Transitional Year, 1978 - 1979
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1978
Certifications & Licensure
NC State Medical License 1979 - 2024
MN State Medical License 1986 - 1989- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Female Pelvic Medicine and Reconstructive Surgery
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2018
- America's Top Doctors for Cancer Castle Connolly, 2005-2018
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012
- Join now to see all
Clinical Trials
- Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
- Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Start of enrollment: 2010 Apr 12
- Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery Start of enrollment: 2012 Jun 04
- Join now to see all
Publications & Presentations
PubMed
- Transvaginal ureteroneocystostomy.Laurel K Berry, Collin M McKenzie, Samuel S Lentz> ;Urology Case Reports. 2023 Nov 1
- 2 citationsCompound C Inhibits Ovarian Cancer Progression via PI3K-AKT-mTOR-NFκB Pathway.Daniela Gonzalez, Hesham Afify, Junjun Shu, Abigail Hegarty, Jemima Adisa, Michael Kelly, Samuel Lentz, Freddie Salsbury, Neveen Said, Ghoneum, A., Alia Ghoneum> ;Cancers. 2022 Oct 18
- 4 citationsThe clinical and prognostic significance of pre-chemotherapy serum CA-125 in high-risk early stage ovarian cancer: An NRG/GOG ancillary study.John K Chan, Chunqiao Tian, Joshua P Kesterson, Michael T Richardson, Ken Lin, Krishnansu S Tewari, Thomas Herzog, Daniel S Kapp, Bradley J Monk, Yovanni Casablanca, P...> ;Gynecologic Oncology. 2022 Dec 1
- Join now to see all
Professional Memberships
- Fellow
Hospital Affiliations
Atrium Wake Forest BaptistWinston Salem, North Carolina- Wake Forest Baptist Health-Lexington Medical CenterLexington, North Carolina
- High Point Medical CenterHigh Point, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
